| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 8,163,000 | 10,167,000 | 7,895,000 | 7,464,000 | | Cost of Revenue | 5,192,000 | 6,635,000 | 5,156,000 | 4,864,000 | | | Gross Profit | 2,971,000 | 3,532,000 | 2,739,000 | 2,600,000 | | | Operating Expenses | | Research Development | 319,000 | 315,000 | 298,000 | 292,000 | | Selling General and Administrative | 985,000 | 1,091,000 | 999,000 | 916,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,667,000 | 2,126,000 | 1,442,000 | 1,392,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 63,000 | 158,000 | 140,000 | 118,000 | | Earnings Before Interest And Taxes | 1,730,000 | 2,284,000 | 1,582,000 | 1,510,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,730,000 | 2,284,000 | 1,582,000 | 1,510,000 | | Income Tax Expense | 525,000 | 679,000 | 446,000 | 438,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,205,000 | 1,605,000 | 1,136,000 | 1,072,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,205,000 | 1,605,000 | 1,136,000 | 1,072,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,205,000 | $1,605,000 | $1,136,000 | $1,072,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
